
Peter Andersen
@peter19791979
Data Manager
Centre For Liver Research, FLASH
Odense University Hospital, Denmark
Tweeting about work
ID: 1534560358937018368
08-06-2022 15:38:23
77 Tweet
62 Followers
70 Following

Excited to be participating in #EASLCongress next week in Vienna! It'll be my first time there. Looking forward to seeing my colleague Helle Lindholm Schnefeld present her poster on health-related quality of life. #FLASH_OUH

📢 Don't miss Helle Lindholm Schnefeld's presentation on health-related quality of life at the Nurses and AHPs Poster Tour during #EASLCongress 🌟 Join us on Wednesday 21st as she'll unveil the impacts of obesity and alcohol, on our well-being. Let's tackle these challenges together 💪

How to monitor patients with ArLD?🍺⏱️ 🔊We might have a suggestion.. Katrine H. Thorhauge will present our data on repeated LSMs in ArLD at the #EASLCongress Saturday 10:00 at the General Hep. Track Hub and in the poster area Friday (FRI-479). Come by 🙏






New Comment - Israelsen et al - MetALD: new opportunities to understand the role of alcohol in steatotic liver disease thelancet.com/journals/langa… #LiverTwitter #MetALD Mads Israelsen Aleksander Krag Maja Thiele


LiverRisk score published The Lancet LiverScreen H2020 ➡️ low vs high HR=471 for liver related mortality 😳 Next generation first line liver fibrosis test?🤔 👉Diagnostic AUC 0.83 vs FIB4 0.68 👉Prognostic (liver related outcomes) AUC 0.90 vs FIB4 0.84 authors.elsevier.com/c/1hZE5V-4XL36T


❗️ Infections = worse prognosis in early ALD❗️ Just published in JHEP Reports 🦠 Despite early stage ALD, high incidence of infections: 1/3 during 4.5 years 🦠 Infections: Risk of death 8 times up 🦠 Risk of decompensation 5 times up 🔗 jhep-reports.eu/article/S2589-…




Liver stiffness to predict AND monitor outcomes in ALD 1️⃣xLSM in 536🧑🤝🧑 2️⃣xLSM in 371🧑🤝🧑 after ~2 y 5️⃣y. Outcome follow-up LSM going up ⤴️, so is the risk of decompensation and mortality ☠️🏥 journal-of-hepatology.eu/article/S0168-… MICROB-PREDICT GALAXY 🇪🇺 Vienna Liver News FLASH - Liver Research



I am so proud of the first results coming out from FLASH - Liver Research DECIDE & LiverScreen H2020 cohort. It all started with an idea, protocol and first patient in 2017, supported by #Horizon2020 Novo Nordisk Foundation funding Now: Mads Israelsen summing up at the big stage #EASLcongress





ALB TRIAL investigator meeting in the sun at #EASLCongress MICROB-PREDICT FLASH - Liver Research
